Younger Patients With Multiple Myeloma Can Achieve Durable Survival

THURSDAY, July 27, 2023 -- Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median progression-free survival (PFS) of approximately 3.5 years and a median overall survival (OS) of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news